(Phys.org)—A team of researchers in Canada has found a way around the problem of large nanostructures that are used to combat tumors,remaining in the body after they are no longer needed.In their paper published in the journal Nature ...
Tags: Decomposable Nanostructures, cancer, tumor
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have ...
Tags: triple negative, Curie-Cancer, TTK/MPS1, Institut Curie and Servier
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy. There is currently no proven screening test or method ...
Tags: QUT, ovarian cancer, Katie Clift, 3D modelling
US-based FOB Synthesis and AstraZeneca have entered into a research and development option and license agreement for the development of a novel antibiotic for the treatment of drug-resistant bacterial infections. The new antibiotics will ...
Tags: FOB, BLI, AstraZeneca
BioAlliance Pharma, an innovative Company dedicated to the development of orphan oncology, announced today that Validive (clonidine Lauriad) received a Fast Track designation from the US Food and Drug Administration (FDA) for the prevention ...
Tags: FDA, BioAlliance Pharma, disease, Validive
Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy (AHTRT), remains the gold standard regimen for patients with limited-stage small-cell lung cancer (SCLC), Japanese researchers say. The phase ...
Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Tags: a
Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
A new combination of drugs might prolong life in certain older leukemia patients, a new study suggests. The research, led by German scientists, included nearly 800 older people (average age 73) who had been diagnosed with chronic ...
Tags: Drug, Drug Combo, Leukemia
In 2004, a form of cancer known as neuroblastoma claimed the life of Alexandra (Alex) Scott, a little girl who gained national attention for using her lemonade stand to raise money for cancer research. Now, the organization established in ...
Tags: neuroblastoma, Alex's Lemonade Stand Foundation, University of Maryland
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration ...
Tags: Bispecific Antibodies, Sutro's Cell-Free Protein Synthesis Technology
Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was ...
Tags: create nanoparticles, cancer-killing drugs, breast cancer, cancer cell
HealthDay Reporter Latest Cancer News Pain One Year After Breast Cancer Surgery Experimental Treatment for Rare Soft-Tissue Cancer Cancer Patients Vulnerable to Flu Complications Surgery With Radiation Best for Tongue Cancer Only High-Risk ...
Tags: Health, Medicine, Childhood Cancer
One year after breast cancer surgery, many women continue to experience pain, according to a new study. Researchers revealed that the factors associated with the women's pain included chronic pain and depression before surgery, ...
Women with aggressive breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a slightly improved chance of staying cancer-free, researchers say. However, the improvement was not statistically ...
Tags: aggressive breast cancer, targeted therapy with chemotherapy